UCLA Technology Development Group

Recently published in ACS Applied Materials & Interfaces: the novel surgical mesh permanent implant. This bacterial nanocellulose (BNC) exhibits promising biocompatibility and mechanical properties that can be used as a long-term treatment for tissue repair and tension free surgical fixation applications, including hernia. Find out more here: https://lnkd.in/gdhW-SxR.

?? Drumroll for... our LA Tech Week Panel Moderator - Amir Naiberg ?? ?? Amir Naiberg leads the UCLA Technology Development Group, a campus-wide resource that serves as a Gateway to Innovation, Research and Entrepreneurship at UCLA. ?? As CEO and President, Amir works in concert with several on campus incubators and accelerators to further advance university ventures. Don't miss out on an engaging conversation with UCLA ecosystem founders, investors, and partners! ?? ?? RSVP today and secure your spot: (https://lnkd.in/gP_yDX87) #LATechWeek #UCLA #Startups #Tech #VC #Entrepreneurship

Check out one of the latest innovations from UCLA researchers, featured by UCLA Health! An interdisciplinary team has developed a cutting-edge deep-learning framework called SLIViT (SLice Integration by Vision Transformer) that automatically analyzes and diagnoses 3D medical images like MRIs, retinal scans, and CTs. SLIViT significantly reduces the time and resources required for medical image analysis while maintaining diagnostic accuracy comparable to expert specialists. What sets SLIViT apart is its adaptability across various imaging modalities and its ability to train on moderately sized datasets, overcoming limitations faced by other 3D imaging models. With applications in diagnosing liver disease, heart function, and cancer screening, SLIViT offers groundbreaking potential to streamline clinical workflows, reduce data acquisition costs, and accelerate medical research. Find out more here: https://lnkd.in/gMzb4Rg4. This technology was also recently published in Nature Biomedical Engineering: https://lnkd.in/gnzcver6. Eran Halperin Oren Avram, PhD Berkin Durmus Nadav Rakocz SriniVas Sadda

?? Panel Spotlight for BioscienceLA Week 2024! ?? We are excited to highlight our upcoming panel on “Career Possibilities - Company/Hiring Focus” during BioscienceLA Week 2024 moderated by Dr. Chander Arora, Dean of Academic Affairs, Los Angeles Mission College Introducing our esteemed panelists: - Dan St. Peter, MBA, PMP, Head of Manufacturing, ImmPACT Bio - Dr. Dhruv Sareen, Executive Director, Cedars-Sinai Biomanufacturing Center - Maung L.,Global HR Director, Abbot - Regan Gabrillo, Senior Recruiter, Grifols Don’t miss the chance to hear from industry leaders and engage in the conversation shaping the future of bioscience in LA County! ?? Join us for this insightful panel and be part of the momentum pushing LA’s bioscience sector forward. Register today - https://lu.ma/pzovfnc3 A special thanks to our sponsor JLL Presented by Los Angeles County Economic Development Corporation (LAEDC), Los Angeles County Economic Development Corporation (LAEDC), Larta Institute, BioscienceLA #BioscienceLA #BioscienceLAWeek #GrowLABio #BioscienceInnovation #LACommunity

The recording of our recent Veranex webinar on FDA's evolving regulation of Laboratory Developed Tests (LDTs) is now available! Gain valuable insights from this expert panel, including Amit Kumar Jain, MBA, Banu Saritas-Yildirim, Jai Pandey, PhD, Jennifer Dacpano-Komansky, and Shannon Bennett. They shared practical strategies for navigating these regulatory changes, ensuring compliance, and preventing commercial disruption. Don't miss out—watch the session to stay ahead in the #LDT space!

?? Exciting News in Diabetes Care! Led by Professor Aydogan Ozcan, researchers at UCLA have developed an insertable glucose sensor that promises to transform how we monitor blood sugar levels via continuous glucose monitoring (CGM). This new device uses advanced imaging techniques and machine learning to deliver highly accurate glucose readings. Unlike traditional methods that require painful finger pricks, this sensor is designed for comfort and convenience, lasting up to 90 days after implantation. It’s not only cost-effective but also helps reduce complications and represents a significant advancement in optical methods for CGM.????Find out more about this innovation: https://lnkd.in/guqKJuSY Access the publication here: https://lnkd.in/gaPeJR3J. #DiabetesCare #ContinuousGlucoseMonitoring

TDG's Tariq Arif will be attending the Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa October 7-9 in Phoenix. Connect with him there to discuss UCLA cell and gene therapy technologies and opportunities for collaboration. https://lnkd.in/gxUKy5aD #CGMesa24 Parker Institute for Cancer Immunotherapy

Excited to be attending the Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa October 7-9 in Phoenix. This gathering of senior leaders and key decision makers in cell and gene therapy is an important platform to exchange ideas, tackle challenges and discuss collaborations that will propel meaningful progress. Look forward to connecting!! https://lnkd.in/gxUKy5aD

Several UCLA researchers were recently awarded a $1M NSF grant to facilitate the advancement and commercialization of quantum sensing technologies. Led by UCLA physicist David Leibrandt, the Quantum Sensing and Imaging Lab?(Q-SAIL) will develop advanced quantum sensors using two-dimensional trapped-ion arrays, enabling precise measurements for various applications. The project involves collaboration across multiple universities and industry partners to advance sensor technology development. This initiative is part of the NSF's National Quantum Virtual Laboratory (NQVL), a program designed to democratize access to quantum research and commercialize new technologies. Discover UCLA's robust quantum portfolio: https://lnkd.in/gX4ndNs3 Credit: https://lnkd.in/gmYysAh5 Aydogan Ozcan Prineha Narang Chee Wei Wong Mona Jarrahi Shanna Shaked

Congratulations Equatic Ltd on being a finalist! Check out 0:26 on the video!